2025: Cure Parkinson's research highlights from the last year and insights for the year ahead
2024 was another busy year for the research team at Cure Parkinson’s; from the results publication of the phase 2 clinical trial of lixisenatide to the funding of new pre-clinical projects, Cure Parkinson’s has not stopped in its mission to slow, stop or reverse Parkinson’s....
Learn more
Webinar – Coronavirus and Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. This webinar discusses recent publications about Coronavirus and Parkinson’s. The eminent panel, once again chaired by Professor Patrik Brundin (Van Andel Institute) comprises Dr Alberto Fasano (University of Toronto), Dr David Beckham…
Webinar – Prodromal Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. Prodromal Parkinson’s is the stage at which individuals exhibit signs and symptoms that indicate a higher than average risk of developing motor symptoms and a diagnosis of Parkinson’s in the future. The…
Webinar – Neurotrophic Factors and Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. The panel of experts include: Chair – Prof Patrik Brundin, Dr. Howard Federoff – Professor of Neurology and Neuroscience, University of California; Prof. Mart Saarma – Research Director, University of Helsinki and…
Webinar – Exercise and Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. Re-watch our webinar discussing recent publications around the theme of exercise in Parkinson’s. The panel, once again chaired by Van Andel Institute’s Professor Patrik Brundin comprises clinical expertise from Professor Bas Bloem…
Webinar – Dyskinesia in Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. Chair Professor Patrik Brundin is joined by fellow panellists Professor Ray Chaudhuri from Kings College London, Professor Angela Cenci Nilsson from Lund University in Sweden with patient perspectives from Martin Taylor, founder…